HR POSITIVE HER2 NEGATIVE

New Breast Cancer Drug Capivasertib Approved by NHS IN UK

"People with advanced breast cancer would value treatments like capivasertib that can be given when limited options exist and because it may delay the need for chemotherapy and its associated side-effects," said NICE's director of medicines evaluation, Helen Knight.